N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
What is the purpose of this trial?
The objective of this application is to examine whether, given its mechanism of action, the dietary supplement, N-acetyl cysteine (NAC) will reduce both tobacco use and pathological gamblers (PG) symptoms in nicotine dependent pathological gamblers.
- 18 Years - 75 Years
- National Institute on Drug Abuse (NIDA)
University of Minnesota - Clinical and Translational Science Institute
- September 2009
- Last Updated:
- March 10, 2014
- Study HIC#:
Clinicaltrials.gov ID: NCT00967005